Showing 25 to 36 of 80 results
US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
Progress
52% Bias Score
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Weight-Loss Injections Pose Contraceptive Risks: Urgent MHRA Warning
The UK's MHRA issued an urgent warning that weight-loss injections, including Ozempic, Wegovy, and Mounjaro, may reduce contraceptive effectiveness and pose risks to pregnant women and fetuses, prompting advice on birth control and immediate cessation upon pregnancy.
Progress
60% Bias Score
Off-Label Weight Loss Drugs: A Global Health Crisis
The global demand for rapid weight loss fuels a controversial trend: the widespread off-label use of prescription diabetes medications like Ozempic and Mounjaro, obtained easily through unregulated online platforms and unofficial channels, posing serious health risks.
Off-Label Weight Loss Drugs: A Global Health Crisis
The global demand for rapid weight loss fuels a controversial trend: the widespread off-label use of prescription diabetes medications like Ozempic and Mounjaro, obtained easily through unregulated online platforms and unofficial channels, posing serious health risks.
Progress
56% Bias Score
MHRA Warns of Pregnancy Risk with Weight-Loss Drugs
The UK's MHRA issued a warning about 40 reported pregnancies in women using weight-loss drugs like Ozempic, Wegovy, and Mounjaro, advising them to use effective contraception due to potential interactions and lack of safety data during pregnancy.
MHRA Warns of Pregnancy Risk with Weight-Loss Drugs
The UK's MHRA issued a warning about 40 reported pregnancies in women using weight-loss drugs like Ozempic, Wegovy, and Mounjaro, advising them to use effective contraception due to potential interactions and lack of safety data during pregnancy.
Progress
52% Bias Score
Weight-Loss Drugs Linked to Increased Osteoporosis Risk
Weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may cause significant bone and muscle loss, increasing osteoporosis risk, according to the Royal Osteoporosis Society. Up to 40 percent of weight loss from these drugs may come from bone and muscle, impacting approximately half a million users ...
Weight-Loss Drugs Linked to Increased Osteoporosis Risk
Weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may cause significant bone and muscle loss, increasing osteoporosis risk, according to the Royal Osteoporosis Society. Up to 40 percent of weight loss from these drugs may come from bone and muscle, impacting approximately half a million users ...
Progress
56% Bias Score
Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Progress
44% Bias Score
UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.
UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.
Progress
64% Bias Score
GLP-1 RA Drugs May Double Macular Degeneration Risk in Diabetic Patients
A Canadian study of over 1 million Ontario residents with diabetes revealed that GLP-1 RA drugs, such as semaglutide and lixisenatide, may at least double the risk of developing neovascular age-related macular degeneration after six months of use, particularly in older patients or those with a histo...
GLP-1 RA Drugs May Double Macular Degeneration Risk in Diabetic Patients
A Canadian study of over 1 million Ontario residents with diabetes revealed that GLP-1 RA drugs, such as semaglutide and lixisenatide, may at least double the risk of developing neovascular age-related macular degeneration after six months of use, particularly in older patients or those with a histo...
Progress
48% Bias Score
Ozempic Linked to Doubled Risk of Blinding Eye Condition
An Israeli study of 139,000 type 2 diabetes patients found those using Ozempic or similar weight-loss drugs were twice as likely to develop the blinding eye condition neovascular age-related macular degeneration (nAMD) compared to a control group, prompting further research into the drugs' potential...
Ozempic Linked to Doubled Risk of Blinding Eye Condition
An Israeli study of 139,000 type 2 diabetes patients found those using Ozempic or similar weight-loss drugs were twice as likely to develop the blinding eye condition neovascular age-related macular degeneration (nAMD) compared to a control group, prompting further research into the drugs' potential...
Progress
60% Bias Score
Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.
Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.
Progress
60% Bias Score
UK Obesity Crisis: Weight-Loss Drug Success Creates Dangerous Black Market
In the UK, the rising popularity of GLP-1 weight-loss medication like Wegovy and Ozempic, despite strict NHS access, has created a black market with reports of misuse leading to hospitalizations; while effective for weight loss and related health problems, unregulated access poses serious health ris...
UK Obesity Crisis: Weight-Loss Drug Success Creates Dangerous Black Market
In the UK, the rising popularity of GLP-1 weight-loss medication like Wegovy and Ozempic, despite strict NHS access, has created a black market with reports of misuse leading to hospitalizations; while effective for weight loss and related health problems, unregulated access poses serious health ris...
Progress
44% Bias Score
Ozempic Mouth": Risks of Rapid Weight Loss and Safe Alternatives
The article discusses "Ozempic Mouth," facial changes from rapid weight loss using GLP-1 drugs like Ozempic, highlighting risks including increased gallstones, pancreatitis, and hair loss, alongside safe weight loss strategies emphasizing gradual weight loss (0.5-1kg/week) and balanced nutrition.
Ozempic Mouth": Risks of Rapid Weight Loss and Safe Alternatives
The article discusses "Ozempic Mouth," facial changes from rapid weight loss using GLP-1 drugs like Ozempic, highlighting risks including increased gallstones, pancreatitis, and hair loss, alongside safe weight loss strategies emphasizing gradual weight loss (0.5-1kg/week) and balanced nutrition.
Progress
56% Bias Score
Showing 25 to 36 of 80 results